---
$id: https://graph.org.ai/products/commodity/51111606
$type: Product
source: UNSPSC
code: "51111606"
title: "Hydroxycarbamide or hydroxyurea"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hydroxycarbamide or hydroxyurea

**UNSPSC Code**: 51111606
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a ribonucleotide reductase inhibitor and miscellaneous antimetabolite with the molecular formula CH4N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X6Q56QN5QC, chemically known as urea, n-hydroxy- but generally known as hydroxycarbamide, which bears US NIH Compound Identifier 3657. European Medicines Agency schedules Hydroxycarbamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08076MIG. The term HYDROXYCARBAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules hydroxycarbamide in its Anatomical Therapeutic Chemical (ATC) Classification. HYDROXYCARBAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HYDROXYUREA remains the US FDA Preferred Term for this commodity. Hydroxyurea bears US NLM identifiers UMLS ID C0020402 and NCI Concept Code C560. SMILES: ONC(=O)N.

